1
|
Stoffner D, Banthien F, Habersetzer R, Samtleben W, Clemm C, Unterburger P, Zähringer J, Gurland H. Plasma Exchange and Concomitant Therapy in TTP. Int J Artif Organs 2018. [DOI: 10.1177/039139888400700413] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- D. Stoffner
- First Medical Clinic, Munich, Federal Republic of Germany
| | | | - R. Habersetzer
- First Medical Clinic, Munich, Federal Republic of Germany
| | - W. Samtleben
- First Medical Clinic, Munich, Federal Republic of Germany
| | - C. Clemm
- Third Medical Clinic, University Hospital Munich-Grosshadern, Munich, Federal Republic of Germany
| | - P. Unterburger
- Second Medical Clinic, Munich, Federal Republic of Germany
| | - J. Zähringer
- First Medical Clinic, Munich, Federal Republic of Germany
| | - H.J. Gurland
- First Medical Clinic, Munich, Federal Republic of Germany
| |
Collapse
|
2
|
Stieber P, Dienemann H, Hasholzner U, Fabricius PG, Schambeck C, Weinzierl M, Poley S, Samtleben W, Hofmann K, Meier W. Comparison of Cyfra 21–1, Tpa and Tps in Lung Cancer, Urinary Bladder Cancer and Benign Diseases. Int J Biol Markers 2018; 9:82-8. [PMID: 7523546 DOI: 10.1177/172460089400900204] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Recently CYFRA 21–1, a new tumor marker measuring a fragment of cytokeratin 19, was introduced and proved to be suitable for therapy monitoring and follow-up of non-small cell lung carcinomas (NSCLC), in particular squamous cell carcinomas. Besides CYFRA 21–1 there are two other tumor markers, tissue polypeptide antigen (TPA) and tissue polypeptide-specific antigen (TPS), which also measure various cytokeratins in serum. In a retrospective study we investigated the clinical significance of these three cytokeratin markers in lung cancer and in carcinoma of the urinary bladder. For this purpose we investigated the sera of 50 healthy persons, 273 patients with various benign diseases, 218 patients with histologically proven lung cancer and 88 patients with carcinoma of the urinary bladder. In a first step the specificity was established for the different reference groups and the cutoff values were fixed at a specificity of 95%. In lung cancer the single and combined sensitivities were calculated versus benign lung diseases (n = 58) as reference group. With single determinations CYFRA 21–1 proved to have the highest sensitivity in lung cancer in general (61%), in non-small cell lung carcinomas (64%), in squamous cell carcinomas (79%), in adenocarcinomas (54%) and in large cell carcinomas (65%). In small cell lung carcinomas (SCLC) NSE was confirmed to be the marker of choice (55%). With combined determinations a clear increase in sensitivity could only be reached in large cell carcinomas (CYFRA 21–1 + TPA: 77%) and in small cell carcinomas (CYFRA 21–1 + NSE: 62%). In cancer of the urinary bladder the sensitivities were established versus benign urological diseases (n = 73). CYFRA 21–1 showed with 38% true positive test results the highest sensitivity compared to TPA (27%) and TPS (23%). From our investigations it was evident that TPA detects at least partially the same substance as CYFRA 21–1 (the sensitivities compared to the markers TPS, CEA, SCC and NSE were rather high, but not as high as for CYFRA 21–1) whereas TPS represents a completely different parameter of clinical chemistry (lowest number of true positive test results over the whole investigation), which apparently measures something completely different. These findings cleary correspond with the very recent results of immunoblotting comparing CYFRA 21–1, TPA and TPS.
Collapse
Affiliation(s)
- P Stieber
- Institut für Klinische Chemie, Ludwig-Maximilians-Universität, München-Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Abstract
Membrane and centrifugal apheresis operate on different physical principles but are both capable of efficiently fractionating plasma proteins from whole blood. For therapeutic purposes, both formats yield about the same protein clearance per liter of solute exchanged and neither is significantly more rapid than the other. Only continuous centrifugation can be used to pherese cellular elements and only membrane filter can be deployed in ‘spontaneous’ circuits. Hardware for continuous centrifugation is more expensive and disposables less expensive than for the membrane methods; the ‘crossover’ occurs at 200 treatments. To date, only the centrifugal method is employed for donor apheresis; this may change in the future as membranes can yield a truly platelet-free product and appear to offer a much more rapid collection cycle.
Collapse
Affiliation(s)
- H.J. Gurland
- Department of Nephrology, First Medical Clinic, University Hospital Munich-Grosshadern, Munich, Fed. Rep. of Germany
| | - M.J. Lysaght
- Department of Nephrology, First Medical Clinic, University Hospital Munich-Grosshadern, Munich, Fed. Rep. of Germany
| | - W. Samtleben
- Department of Nephrology, First Medical Clinic, University Hospital Munich-Grosshadern, Munich, Fed. Rep. of Germany
| | - B. Schmidt
- Department of Nephrology, First Medical Clinic, University Hospital Munich-Grosshadern, Munich, Fed. Rep. of Germany
| |
Collapse
|
4
|
Bosch T, Samtleben W, Thiery J, Gurland H, Seidel D. Reverse Flux Filtration: A New Mode of Therapy Improving the Efficacy of Heparin - Induced Extracorporeal Ldl Precipitation in Hyperlipidemic Hemodialysis Patients. Int J Artif Organs 2018. [DOI: 10.1177/039139889301600204] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In the steady state after a run-in phase of 3 months, the acute effects of 3 modifications of weekly heparin-induced extracorporeal LDL precipitation (HELP) were studied in 5 ESRD and 2 non-uremic hypercholesterolemic coronary patients. In ESRD patients (n=29 sessions), HELP reduced LDL-cholesterol (LDL-C) (56 ± 7%) and fibrinogen (FIB) (54 ± 10%) by a similar percentage as compared to non-uremic controls (60 ± 4% and 61 ± 3%, resp.; n=5). In order to eliminate the need for extra HELP sessions in addition to the normal dialysis regimen, newly developed hardware was then used to perform combined synchronous HELP/HD (n=12). However, premature precipitate filter plugging probably due to hyperfibrinogenemia in ESRD patients, accentuated by ultrafiltration (UF), decreased the corresponding reductions to 26 ± 9% (LDL-C) and 34 ± 11% (FIB). Therefore, the procedure was modified by reversing the filtrate flux through the precipitate filter membrane after 900 ml of treated plasma (“reverse flux filtration”, RFF; n=11). Thus, in RFF-HELP/HD the LDL/FIB/heparin coprecipitate was deposited on both filter membrane sides which caused a significant enhancement of the filter capacity and improved reductions to 46 ± 14% for LDL-C and 51 ± 15% for FIB. Elution of the precipitate from the precipitate filter after the sessions showed that RFF-HELP/HD had trapped 1733 ± 238 mg LDL-C and 8108 ± 1876 mg FIB in ESRD patients, while HELP eliminated 1890 ± 333 mg LDL-C and only 3663 ± 369 mg FIB in non-uremics. Filter precipitate recoveries (relative to the mass removed from the patient plasma pool) amounted to 97 ± 18% for LDL-C and 158 ± 67% for FIB in the ESRD group treated by RFF-HELP/HD vs. 70 and 76% in the non-uremic HELP group. Probably, passive transport of lipoproteins and FIB from the interstitium into the vascular space caused repletion of this compartment during HELP/HD where an UF induced solvent drag is effective. In summary, the new RFF-HELP/HD procedure effectively reduced LDL-C and FIB in ESRD patients who could not be adequately treated by the conventional HELP/HD system.
Collapse
Affiliation(s)
- T. Bosch
- Department of Nephrology, Medical Clinic I and University of Munich - Germany
| | - W. Samtleben
- Department of Nephrology, Medical Clinic I and University of Munich - Germany
| | - J. Thiery
- Institute of Clinical Chemistry, Klinikum Großhadern, University of Munich - Germany
| | - H.J. Gurland
- Department of Nephrology, Medical Clinic I and University of Munich - Germany
| | - D. Seidel
- Institute of Clinical Chemistry, Klinikum Großhadern, University of Munich - Germany
| |
Collapse
|
5
|
Abstract
Adsorbents from four commercially available devices, Protein A-Sepharose (Immunosorba Protein A-62,5; Excorim KB, Lund Sweden), Tryptophan-PVA (Immusorba TR-350; Asahi Medical Co., Tokyo, Japan), Phenylalanine-PVA (Immusorba PH-350; Asahi Medical Co., Tokyo, Japan), and Dextran sulfate (Liposorber LA-15; Kanegafuchi Chemical Co. Ltd, Osaka, Japan) were tested under optimal in vitro conditions to determine their adsorption capability for several plasma constituents which are usually the target of plasma therapy. The parameters of interest were: double stranded DNA-antibodies (anti-dsDNA), antiglomerular basement membrane antibodies (anti-GBM), antiacetylcholin receptor antibodies (AChRAb), circulating immune complexes (CIC), rheumatoid factor (RF), IgA, IgG, IgM, IgE, C3c, C4, LDL-cholesterol, total cholesterol, erythropoietin (EPO) and β2-microglobulin (β2M). The IgG auto antibodies, CIC and RF can be removed by Protein A-Sepharose, Try-PVA and Phe-PVA. IgG is best adsorbed by Protein A-Sepharose, while IgE can be removed effciently by Try-PVA. Dextran sulfate is without doubt the best adsorbent for LDL-cholesterol. All four adsorbents bind also complement components C3c and C4. No significant adsorption was found for EPO and β2M. The four devices exhibit a quite different adsorption profile which can be used as a guide for the optimal selection of an adsorption column in clinical apheresis.
Collapse
Affiliation(s)
- V. Ikonomov
- Nephrology Department, Med. Klinik I, University of Munich, Munich - Germany
- Klinikum Grosshadern, University of Munich, Munich - Germany
| | - W. Samtleben
- Nephrology Department, Med. Klinik I, University of Munich, Munich - Germany
- Klinikum Grosshadern, University of Munich, Munich - Germany
| | - B. Schmidt
- Nephrology Department, Med. Klinik I, University of Munich, Munich - Germany
- Klinikum Grosshadern, University of Munich, Munich - Germany
| | - M. Blumenstein
- Nephrology Department, Med. Klinik I, University of Munich, Munich - Germany
- Klinikum Grosshadern, University of Munich, Munich - Germany
| | - H.J. Gurland
- Nephrology Department, Med. Klinik I, University of Munich, Munich - Germany
- Klinikum Grosshadern, University of Munich, Munich - Germany
| |
Collapse
|
6
|
Wendler T, Lennertz A, Heinemann O, Duhr C, Samtleben W, Bosch T. Heparin-Free DALI LDL-Apheresis in Hyperlipidemic Patients: Efficacy, Safety and Biocompatibility. Int J Artif Organs 2018. [DOI: 10.1177/039139880002301009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background and Aim of Study In routine DALI apheresis - the first technique for direct adsorption of lipoproteins from whole blood - heparin plus citrate (ACD-A) is used as anticoagulation regimen. However, recently several publications have warned of heparin-induced thrombocytopenia as a rare but potentially life-threatening complication of heparin administration (HIT type 2). The aim of the present study was therefore to test the efficacy and biocompatibility of DALI using a heparin-free anticoagulation regimen consisting exclusively of citrate. Methods Four symptomatic hypercholesterolemic patients on regular DALI apheresis were switched to the heparin-free protocol for two sessions each. Two of the patients were on oral anticoagulation using phenprocoumon. In the weekly sessions, 1.3 patient blood volumes were processed at a blood flow rate of 60 ml/min using ACD-A at a ratio of 1:20 (v/v) during adsorber priming and the session. Results Clinically, all sessions were essentially uneventful. Uncorrected lipoprotein reductions amounted to 65% for LDL-C, 62% for Lp(a), 53% for VLDL-C, 24% for HDL-C, 17% for triglycerides and 19% for fibrinogen. Cell counts remained virtually constant. No signs of hemolysis or clotting could be detected. Thromboplastin time (Quick) was slightly prolonged and partial thromboplastin time (PTT) moderately elevated in all patients. In constrast, whole blood coagulation time acc. to Lee-White and activated clotting times were increased only in orally anticoagulated patients. Biocompatibility in terms of complement, leukocyte and thrombocyte activation was excellent. Bradykinin activation was moderate peaking at 3038 pg/ml in the efferent line. Systemic thrombin-antithrombin complex (TAT) reflected perfect anticoagulation in orally anticoagulated patients and adequate anticoagulation in the patients without phenprocoumon. Conclusion In this pilot study, heparin-free DALI apheresis was safe and effective and may thus be performed in LDL-apheresis dependent patients who suffer from heparin intolerance.
Collapse
Affiliation(s)
- T. Wendler
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| | - A. Lennertz
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| | - O. Heinemann
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| | - C. Duhr
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| | - W. Samtleben
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| | - T. Bosch
- Nephrology Division, Department of Internal Medicine I, Klinikum Großhadern, University of Munich, Munich - Germany
| |
Collapse
|
7
|
Samtleben W, Lysaght MJ, Blumenstein M, Gurland HJ. Therapeutic plasmapheresis in rheological disorders: Indications and limitations. Clin Hemorheol Microcirc 2016. [DOI: 10.3233/ch-1984-4106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Walter Samtleben
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, 0-8000 Munich 70, Fed. Rep. Germany
| | - Michael J. Lysaght
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, 0-8000 Munich 70, Fed. Rep. Germany
| | - Matthias Blumenstein
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, 0-8000 Munich 70, Fed. Rep. Germany
| | - Hans J. Gurland
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, 0-8000 Munich 70, Fed. Rep. Germany
| |
Collapse
|
8
|
Lysaght MJ, Samtleben W, Schmidt B, Gurland HJ. Technical assessment of membrane plasmapheresis in treatment of a patient with IgM paraproteinemia. Clin Hemorheol Microcirc 2016. [DOI: 10.3233/ch-1985-5105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Michael J. Lysaght
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, D-8000 Munich 70, Fed. Rep. Germany
| | - Walter Samtleben
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, D-8000 Munich 70, Fed. Rep. Germany
| | - Baerbel Schmidt
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, D-8000 Munich 70, Fed. Rep. Germany
| | - Hans J. Gurland
- First Medical Clinic, University Hospital Munich-Grosshadern, P.O. Box 701260, D-8000 Munich 70, Fed. Rep. Germany
| |
Collapse
|
9
|
Samtleben W, Ehmer B, Lutz-Knochenhauer I, Hagmann C, Scigalla P, Gurland HJ. Side effects during recombinant human erythropoietin therapy in 2,000 ESRD patients. Contrib Nephrol 2015; 88:107-16; discussion 117. [PMID: 2040172 DOI: 10.1159/000419520] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- W Samtleben
- Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, FRG
| | | | | | | | | | | |
Collapse
|
10
|
Bommer J, Samtleben W, Koch KM, Baldamus CA, Grützmacher P, Scigalla P. Variations of recombinant human erythropoietin application in hemodialysis patients. Contrib Nephrol 2015; 76:149-56; discussion 156-8. [PMID: 2684517 DOI: 10.1159/000417891] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- J Bommer
- Nephrology Division, I. Medizinische Universitätsklinik, Heidelberg, FRG
| | | | | | | | | | | |
Collapse
|
11
|
Affiliation(s)
- H J Gurland
- Department of Nephrology, Klinikum Grosshadern, University of Munich, FRG
| | | | | |
Collapse
|
12
|
Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ. Blood pressure changes during treatment with recombinant human erythropoietin. Contrib Nephrol 2015; 66:114-22. [PMID: 3292144 DOI: 10.1159/000416009] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- W Samtleben
- Nephrology Division, Klinikum München-Grosshadern, Ludwigs-Maximilians University, München, FRG
| | | | | | | | | | | |
Collapse
|
13
|
Pfåffl W, Gross HJ, Neumeier D, Nattermann U, Samtleben W, Gurland HJ. Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin. Contrib Nephrol 2015; 66:195-204. [PMID: 3391032 DOI: 10.1159/000416018] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- W Pfåffl
- Nephrology Division, Klinikum München-Grosshadern, Ludwigs-Maximilians-University, München, FRG
| | | | | | | | | | | |
Collapse
|
14
|
Bosch T, Schmidt B, Samtleben W, Gurland HJ. Effect of protein adsorption on diffusive and convective transport through polysulfone membranes. Contrib Nephrol 2015; 46:14-22. [PMID: 4006473 DOI: 10.1159/000410763] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
15
|
|
16
|
Strauer BE, Fateh-Moghadam A, Kment A, Samtleben W, Volger E. Use of plasmapheresis and immunosuppressive therapy in coronary microangiopathies. Bibl Haematol 2015:213-27. [PMID: 7337663 DOI: 10.1159/000402228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
17
|
Schormair B, Plag J, Kaffe M, Gross N, Czamara D, Samtleben W, Lichtner P, Ströhle A, Stefanidis I, Vainas A, Dardiotis E, Sakkas GK, Gieger C, Müller-Myhsok B, Meitinger T, Heemann U, Hadjigeorgiou GM, Oexle K, Winkelmann J. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet 2011; 48:462-6. [PMID: 21572129 PMCID: PMC3122881 DOI: 10.1136/jmg.2010.087858] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
Abstract
Background Restless legs syndrome (RLS) is a sleep related movement disorder that occurs both in an idiopathic form and in symptomatic varieties. RLS is a frequent and distressing comorbidity in end stage renal disease (ESRD). For idiopathic RLS (iRLS), genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case–control association study of these variants in ESRD patients was performed. Methods The study genotyped 10 iRLS associated variants at four loci encompassing the genes MEIS1, BTBD9, MAP2K5/SKOR1, and PTPRD, in two independent case–control samples from Germany and Greece using multiplex PCR and MALDI-TOF (matrix assisted laser desorption/ionisation time-of-flight) mass spectrometry. Statistical analysis was performed as logistic regression with age and gender as covariates. For the combined analysis a Cochran–Mantel–Haenszel test was applied. Results The study included 200 RLS-positive and 443 RLS-negative ESRD patients in the German sample, and 141 and 393 patients, respectively, in the Greek sample. In the German sample, variants in MEIS1 and BTBD9 were associated with RLS in ESRD (Pnom≤0.004, ORs 1.52 and 1.55), whereas, in the Greek sample, there was a trend for association to MAP2K5/SKOR1 and BTBD9 (Pnom≤0.08, ORs 1.41 and 1.33). In the combined analysis including all samples, BTBD9 was associated after correction for multiple testing (Pcorrected=0.0013, OR 1.47). Conclusions This is the first demonstration of a genetic influence on RLS in ESRD patients with BTBD9 being significantly associated. The extent of the genetic predisposition could vary between different subgroups of RLS in ESRD.
Collapse
Affiliation(s)
- Barbara Schormair
- Institute of Human Genetics, Helmholtz Zentrum München e German Research Center for Environmental Health, Neuherberg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Durner J, Winkler-Budenhofer U, Gahr S, Samtleben W, Schönermarck U. Pseudohypocalcemia caused by perchlorate (Irenat®). Clin Chem Lab Med 2011; 49:665-7. [DOI: 10.1515/cclm.2011.113] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
19
|
Op den Winkel M, Gülberg V, Weiss M, Ebeling F, Gerbes AL, Samtleben W. Acute postinfectious glomerulonephritis associated with Campylobacter jejuni enteritis - a case report and review of the literature on C. jejuni's potential to trigger immunologically mediated renal disease. Clin Nephrol 2010; 74:474-479. [PMID: 21084052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
Kidney disease is a rare complication of Campylobacter jejuni (C. jejuni) enteritis. We here present the case of an 18-year-old male patient with crampy abdominal pain, vomiting, diarrhea, and fever. Three weeks later urinalysis revealed mild proteinuria and hematuria and a marked raise in serum creatinine was observed. Renal biopsy demonstrated acute endocapillary glomerulonephritis with mesangial IgM (immunoglobuline M) deposits. Extensive workup revealed no signs of skin or joint disease, thus excluding Henoch-Schönlein purpura. Due to persistent abdominal discomfort further gastro-enterological tests were performed and eventually Campylobacter jejuni was isolated from the patient's feces. In the absence of other precipitating factors for renal diseases we presumed an association between the bacterial infection and this postinfectious glomerulonephritis. Over a time period of 6 months the patient's kidney function normalized completely. However, long-term prognosis remains unclear. In addition to the case report, we conducted a review of the literature with results underlining Campylobacter jejuni's potential to trigger various types of immune mediated kidney diseases.
Collapse
Affiliation(s)
- M Op den Winkel
- Department of Medicine II, University-Hospital Munich-Großhadern, Ludwig-Maximilians-University, Munich, Germany.
| | | | | | | | | | | |
Collapse
|
20
|
Bender A, Samtleben W, Elstner M, Klopstock T. Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutr Res 2009; 28:172-8. [PMID: 19083405 DOI: 10.1016/j.nutres.2008.01.001] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2007] [Revised: 01/09/2008] [Accepted: 01/10/2008] [Indexed: 12/12/2022]
Abstract
The food supplement creatine (Cr) is widely used by athletes as a natural ergogenic compound. It has also been increasingly tested in neurodegenerative diseases as a potential neuroprotective agent. Weight gain is the most common side effect of Cr, but sporadic reports about the impairment of renal function cause the most concerns with regard to its long-term use. Data from randomized controlled trials on renal function in Cr-supplemented patients are scarce and apply mainly to healthy young athletes. We systematically evaluated potential side effects of Cr with a special focus on renal function in aged patients with Parkinson disease as well as its current use in clinical medical research. Sixty patients with Parkinson disease received either oral Cr (n = 40) or placebo (n = 20) with a dose of 4 g/d for a period of 2 years. Possible side effects as indicated by a broad range of laboratory blood and urine tests were evaluated during 6 follow-up study visits. Overall, Cr was well tolerated. Main side effects were gastrointestinal complaints. Although serum creatinine levels increased in Cr patients because of the degradation of Cr, all other markers of tubular or glomerular renal function, especially cystatin C, remained normal, indicating unaltered kidney function. The data in this trial provide a thorough analysis and give a detailed overview about the safety profile of Cr in older age patients.
Collapse
Affiliation(s)
- Andreas Bender
- Department of Neurology, University of Munich-Klinikum Grosshadern, 81377 Munich, Germany.
| | | | | | | |
Collapse
|
21
|
Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WHC, Seitz MA, Messer G, Wollenberg A. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 2009; 88:594-6. [PMID: 19002345 DOI: 10.2340/00015555-0514] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A 22-year-old man with a history of cocaine abuse from 2003 to 2005 developed recurrent bleeding of the nasal septum and a progressive cough and dyspnoea. He was admitted to the intensive care unit because of fulminant pneumonia, impaired renal function and progressive general deterioration. While hospitalized, he developed cutaneous vasculitis, thrombosis of the right subclavian and right jugular veins, testicular pain and, eventually, expanding red papules and plaques on the limbs. The symptoms were a diagnostic challenge, until skin biopsy showed immunoglobulin deposits in small vessels and kidney biopsy focal and segmental pauci-immune, crescentic glomerulonephritis. This led, together with anti-neutrophil cytoplasmic antibodies (cANCA and PR3-ANCA), to the diagnosis of Wegener granulomatosis. The number of affected organ systems in our patient exceeds that commonly found in the literature. Several clinical observations of cocaine abuse followed by Wegener granulomatosis suggest an active induction of a PR3-ANCA-positive vasculitis by cocaine.
Collapse
Affiliation(s)
- Sven Neynaber
- Department of Dermatology, Ludwig-Maximilians-University Munich, Frauenlobstr. 9-11, Muenchen, Germany
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Müller-Höcker J, Weiss M, Sitter T, Samtleben W. Fibrillary glomerulonephritis mimicking membranous nephropathy--a diagnostic pitfall. Pathol Res Pract 2009; 205:265-71. [PMID: 19147302 DOI: 10.1016/j.prp.2008.11.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2008] [Revised: 10/09/2008] [Accepted: 11/10/2008] [Indexed: 11/26/2022]
Abstract
Kidney biopsies in 2 females with nephrotic syndrome were suggestive of membranous nephropathy at routine light microscopy and immunohistochemistry. Electron microscopy on re-embedded paraffin tissue, however, revealed that the light microscopic pattern was due to a fibrillary glomerulonephritis with a dominant membranous manifestation. These findings suggest that (a) fibrillary glomerulonephritis may be mis-/under-diagnosed at light microscopy; and (b) in reality, a subset of therapy refractory membranous nephropathies might represent fibrillary glomerulopathies. Therefore, electron microscopy is mandatory in any case of membranous nephropathy with therapy refractory nephrotic syndrome or an unusual immunohistological staining pattern, e.g. with mesangial immunoreactivity.
Collapse
Affiliation(s)
- J Müller-Höcker
- Institute of Pathology, Ludwig-Maximilians-Universität München, Thalkirchnerstr, 36 80337 München, Germany.
| | | | | | | |
Collapse
|
23
|
Plag J, Schormair B, Samtleben W, Müller-Myhsok B, Illig T, Meitinger T, Winkelmann J. The role of MEIS1, BTBD9 and MAP2K5/LBXCOR1 in uraemic RLS – a case-control study in patients with end stage renal disease on maintenance hemodialysis. Akt Neurol 2008. [DOI: 10.1055/s-0028-1086645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
24
|
Affiliation(s)
- Nouhad Mistry‐Burchardi
- Nephrology Division, Department of Internal Medicine I, Grosshadern, Ludwig Maximilians University, Munich, Germany
| | - Ulf Schönermarck
- Nephrology Division, Department of Internal Medicine I, Grosshadern, Ludwig Maximilians University, Munich, Germany
| | - Walter Samtleben
- Nephrology Division, Department of Internal Medicine I, Grosshadern, Ludwig Maximilians University, Munich, Germany
| |
Collapse
|
25
|
Schönermarck U, Kehl K, Samtleben W. Diagnostic performance of fractional excretion of urea and sodium in acute kidney injury. Am J Kidney Dis 2008; 51:870-1; author reply 871. [PMID: 18436107 DOI: 10.1053/j.ajkd.2008.01.032] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Accepted: 01/03/2008] [Indexed: 11/11/2022]
|
26
|
Samtleben W, Blumenstein M, Gurland H, Link F, Müller-Faßbender H, Meurer M. Erfahrungen mit Plasmaaustausch bei schweren Verläufen von Lupus erythematodes*. AKTUEL RHEUMATOL 2008. [DOI: 10.1055/s-2008-1051124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Blumenstein M, Asanuma Y, Habersetzer R, Malchesky P, Samtleben W, Gurland H, Nosé Y. Kontinuierliche Kryofiltration von Plasma bei rheumatoider Arthritis*. AKTUEL RHEUMATOL 2008. [DOI: 10.1055/s-2008-1051098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Abstract
A scleromyxedema-like disease was recognized in 1997. In 2000 this disorder was first published and termed nephrogenic fibrosing dermopathy because all patients had advanced renal failure. In 2006 it was discovered that the patients had a history of a preceding contrast-enhanced magnetic resonance imaging (MRI). All patients had acute or chronic severe renal insufficiency with a glomerular filtration rate (GFR) <30 ml/min per 1.73 m(2). So far a total of about 215 patients with this new skin disorder have been reported to international registries. The skin thickening has a typical histology and begins in the peripheral extremities and progresses proximally, including also the abdominal wall and the head in some patients. NSF involves not only the skin, but also the muscles and other organs (e.g., lungs, heart, eyes) in some patients. Therefore the term nephrogenic systemic fibrosis (NSF) was introduced. Skin fibrosis and sclerosis are usually progressive with disabling contractures of involved joints (knees, hands, feet). NSF may be lethal in up to 28% of patients. Spontaneous remissions are rare. No generally accepted treatment is available. So far, the pathogenesis is not well understood. One hypothesis supposes a role of gadolinium liberated from the contrast agents. As patients with acute or chronic advanced renal failure (GFR <30 ml/min per 1.73 m(2)) including those with hepatorenal dysfunctions are at high risk to develop NSF after exposure to gadolinium-based contrast agents, contrast-enhanced MRI should be avoided in this group and alternative diagnostic procedures should be used whenever possible.
Collapse
Affiliation(s)
- W Samtleben
- Schwerpunkt Nephrologie, Medizinische Klinik und Poliklinik I, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 München, Deutschland.
| |
Collapse
|
29
|
Samtleben W, Gurland HJ. Thomas Bosch, MD, PhD, Professor of Medicine: Some Personal Reflections. Ther Apher Dial 2008. [DOI: 10.1111/j.1744-9987.2007.00534.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
30
|
Abstract
HISTORY AND CLINICAL FINDINGS A 26-year-old woman with no contributory medical history became anuric after several days of nausea and vomiting. She was admitted to our hospital with suspected acute renal failure. INVESTIGATIONS Laboratory tests revealed greatly elevated BUN and creatinine. There was no evidence of postrenal obstruction, infection or systemic disease. Kidney biopsy showed interstitial nephritis. DIAGNOSIS, THERAPY AND CLINICAL COURSE Further questioning revealed poisoning with a nephrotoxic mushroom of the genus Cortinarius, which the patient had eaten together with her husband nine days before admission. The patient's husband developed anuric renal failure, too, and was admitted to our hospital. Hemodialysis was instituted on day 1. More than one year later, both patients remain on chronic dialysis. CONCLUSIONS Intoxication with mushrooms of the genus Cortinarius should be considered in the differential diagnosis of otherwise unexplained acute renal failure, especially in autumn and late summer. These mushrooms can cause an interstitial nephritis. Once dialysis has to be instituted the prognosis is rather poor: 50 % of these patients develop chronic renal failure. So far there is no causative therapy. In case of chronic renal failure, kidney transplantation is possible.
Collapse
Affiliation(s)
- M Wessely
- Medizinische Klinik und Poliklink I, Schwerpunkt Nephrologie, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, Germany.
| | | | | | | | | |
Collapse
|
31
|
Holdenrieder S, Eichhorn P, Beuers U, Samtleben W, Stieber P, Nagel D, Peterfi A, Steinle A, Salih HR. Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism. Anticancer Res 2007; 27:2041-5. [PMID: 17649819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
BACKGROUND Proteolytic shedding of the immunostimulatory NKG2D ligands MICA and MICB from cancer cells constitutes a novel immune escape strategy that diminishes antitumor reactivity by NKG2D-bearing cytotoxic lymphocytes. In consequence, serum levels of soluble MICA and MICB are frequently found to be elevated in cancer disease. PATIENTS AND METHODS As the diagnostic potential depends strongly on the organ-specific benign diseases and is affected by diseases involved in marker metabolism, both markers were analyzed by ELISA in sera of 141 patients with hepatic autoimmune diseases (34 autoimmune hepatitis, 35 primary sclerosing cholangitis, 72 primary biliary cirrhosis), 18 patients with acute bacterial infections, 21 patients with renal insufficiency, 13 patients with cholestasis and 62 healthy individuals. RESULTS Similarly to healthy controls (median sMICA < 30 pg/mL; sMICB < 30 pg/mL), low levels of both markers were generally found in sera of patients with hepatic autoimmune diseases. In contrast, significantly elevated concentrations of sMICA and sMICB were observed in sera of patients with acute infections (median sMICA 890 pg/mL; sMICB 111 pg/mL), in those with renal insufficiency (sMICA 195 pg/mL; sMICB 50 pg/mL), and in those with cholestasis (sMICA 1058 pg/mL; sMICB 146 pg/mL). CONCLUSION While hepatic autoimmune diseases have no general impact on the amount of circulating sMICA and sMICB, acute bacterial infections, renal insufficiency and cholestasis can lead to notably elevated serum levels of the NKG2D ligands.
Collapse
Affiliation(s)
- Stefan Holdenrieder
- Institute of Clinical Chemistry, University Hospital of Munich, 81377 Munich, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Schönermarck U, Dengler C, Ebeling F, Heydenreich M, Hillebrand GF, Samtleben W. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes. Clin Nephrol 2007; 66:357-63. [PMID: 17140165 DOI: 10.5414/cnp66357] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
AIM In patients with end-stage renal disease (ESRD) cardiovascular morbidity and mortality are increased. Apart from traditional and uremia-specific factors oxidative stress has been implicated as a main risk factor. This study investigated the influence of two different high-flux hemodialysis membranes on parameters of oxidative stress during a dialysis session. PATIENTS AND METHODS 14 stable ESRD patients were enrolled in the study and randomly assigned to high-flux hemodialysis using either a polyamide membrane (Polyflux 14; PA group) or a new polysulfone membrane (Diacap Polysulfone HI PS 15; PS group). All patients received 6 treatments with the same membrane. During the 5th treatment parameters of dialysis efficiency, biocompatibility (cell counts, complement C3a, thrombin-antithrombin complex) and oxidative stress (lipid peroxides, total antioxidative capacity) were measured. RESULTS Parameters of dialysis efficiency and biocompatibility were similar in both treatment groups. At the beginning of the dialysis session both groups showed a low to moderate level of oxidative stress and a reduced total antioxidative capacity as compared to healthy controls. Both parameters deteriorated significantly during the extracorporeal procedure with a similar magnitude in both membrane groups. No correlation between oxidative or antioxidative capacity and parameters of biocompatibility or dialysis efficiency could be found. CONCLUSIONS Dialysis with synthetic high-flux membranes induces a temporary deterioration of oxidative stress parameters in ESRD patients despite good dialysis efficiency and biocompatibility.
Collapse
Affiliation(s)
- U Schönermarck
- Department I of Internal Medicine, Nephrology Division, University Hospital Munich Grosshadern, Ludwig Maximilians University, Munich, Germany.
| | | | | | | | | | | |
Collapse
|
33
|
Plag J, Fulda S, Samtleben W, Wetter T, Winkelmann J. Cognition, mood and anxiety in ESRD-patients with and without restless legs syndrome. Akt Neurol 2007. [DOI: 10.1055/s-2007-987807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
34
|
Abstract
Renal artery stenosis (RAS) is the leading cause of secondary hypertension. Magnetic resonance (MR) imaging and in particular MR angiography have evolved into important diagnostic tools for the detection and grading of RAS due to the lack of ionizing radiation and nephrotoxic contrast agent. This review describes state-of-the-art MR angiographic techniques and introduces the reader to current concepts of RAS grading with MR angiography. We compare MR angiography with conventional angiography and intravascular ultrasound as a standard of reference. The technical basis of functional imaging techniques such as arterial spin labeling perfusion measurements, contrast-enhanced perfusion measurements, and MR flow measurements are explained. Their value for the grading and detection of RAS and for the differentiation of renovascular from renal parenchymal disease is discussed. An overview about imaging during and after interventional therapy of RAS and an introduction to the current understanding of prediction of successful interventional therapy finishes this review.
Collapse
Affiliation(s)
- S O Schoenberg
- Institute of Clinical Radiology, University Hospitals Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany.
| | | | | | | | | | | |
Collapse
|
35
|
Holdenrieder S, Eichhorn P, Beuers U, Samtleben W, Schoenermarck U, Zachoval R, Nagel D, Stieber P. Nucleosomal DNA Fragments in Autoimmune Diseases. Ann N Y Acad Sci 2006; 1075:318-27. [PMID: 17108227 DOI: 10.1196/annals.1368.043] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The inadequate response of immune cells to circulating apoptotic products, such as nucleosomal DNA fragments, is assumed to be a potent stimulus for the production of autoantibodies during the pathogenesis and progression of systemic lupus erythematosus (SLE). Here, we analyzed the levels of circulating nucleosomes, caspases, and C-reactive protein in sera of 244 individuals with various autoimmune diseases (155 with autoimmune hepatic disorders, 25 with ANCA-associated vasculitis, and 64 with various connective tissue diseases), and 32 healthy controls. Nucleosomes and caspase activities were significantly elevated in sera of patients with hepatic autoimmune diseases, connective tissue diseases, and particularly in ANCA-associated vasculitis when compared with healthy individuals. Nucleosomes showed a correlation with caspases, and caspases with C-reactive protein, but nucleosomes did not correlate with C-reactive protein. Serum levels of the apoptotic products, nucleosomes, and caspases are increased in various autoimmune diseases but may not be solely responsible for antinucleosome antibody production in SLE patients. It remains to be clarified whether qualitative changes in nucleosomes are linked with pathogenesis and disease progression in SLE.
Collapse
Affiliation(s)
- Stefan Holdenrieder
- Institute of Clinical Chemistry, University Hospital Munich-Grosshadern, Munich, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Schönermarck U, Schirren CA, Mistry-Burchardi N, Weiss M, Eichhorn P, Samtleben W. Interstitial nephritis and high titers of PR3-ANCA: an unusual manifestation of ANCA-associated disease. Clin Nephrol 2006; 64:383-6. [PMID: 16312267 DOI: 10.5414/cnp64383] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
We present the case of a 75-year-old female with weight loss, anemia, systemic signs of inflammation, mild renal insufficiency, microscopic hematuria, mixed glomerular and tubular proteinuria, and high titers of PR3-ANCA. Renal biopsy demonstrated interstitial nephritis with some sclerosed but otherwise normal glomeruli. Extensive work-up showed no signs of granulomatous inflammation or other vasculitic organ involvement. We presumed this to be a rare renal manifestation of ANCA-associated disease with the presence of sclerosed glomeruli suggesting a previous history of glomerular involvement. In view of the absence of active vasculitic or granulomatous disease, treatment was limited to low-dose corticosteroids with good response.
Collapse
Affiliation(s)
- U Schönermarck
- Nephrology Department, Medical Clinic I, University Hospital München-Grosshadern, LMU München, Germany.
| | | | | | | | | | | |
Collapse
|
37
|
Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 2006; 69:1431-7. [PMID: 16395268 DOI: 10.1038/sj.ki.5000048] [Citation(s) in RCA: 101] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Although clearance of beta(2)-microglobulin is greater with hemodiafiltration than with high-flux hemodialysis, beta(2)-microglobulin concentrations after long-term hemodiafiltration are only slightly less than those obtained with high-flux hemodialysis. Resistance to beta(2)-microglobulin transfer between body compartments could explain this observation. beta(2)-Microglobulin kinetics were determined in patients receiving on-line post-dilution hemodiafiltration for 4 h with 18 l of filtration. Plasma beta(2)-microglobulin concentrations were measured during and for 2 h following hemodiafiltration and immediately before the next treatment. The filter clearance of beta(2)-microglobulin was determined from arterial and venous concentrations. The beta(2)-microglobulin generation rate was calculated from the change in the plasma concentration between treatments. The intercompartmental clearance was obtained by fitting the observed concentrations to a two-compartment, variable volume model. The plasma clearance of beta(2)-microglobulin by the filter was 73 +/- 2 ml/min. Plasma beta(2)-microglobulin concentrations decreased by 68 +/- 2% from pre- to post-treatment (27.1 +/- 2.2-8.5 +/- 0.7 mg/l), but rebounded by 32+/-3% over the next 90 min. The generation rate of beta(2)-microglobulin was 0.136 +/- 0.008 mg/min. The model fit yielded an intercompartmental clearance of 82 +/- 7 ml/min and a volume of distribution of 10.2 +/- 0.6 l, corresponding to 14.3 +/- 0.7% of body weight. Hemodiafiltration provides a beta(2)-microglobulin clearance of similar magnitude to the intercompartmental clearance within the body. As a result, intercompartmental mass transfer limits beta(2)-microglobulin removal by hemodiafiltration. This finding suggests that alternative strategies, such as increased treatment times or frequency of treatment, are needed to further reduce plasma beta(2)-microglobulin concentrations.
Collapse
Affiliation(s)
- R A Ward
- Department of Medicine, University of Louisville, Kentucky 40202-1718, USA.
| | | | | | | |
Collapse
|
38
|
Michaely HJ, Schoenberg SO, Oesingmann N, Ittrich C, Buhlig C, Friedrich D, Struwe A, Rieger J, Reininger C, Samtleben W, Weiss M, Reiser MF. Renal Artery Stenosis: Functional Assessment with Dynamic MR Perfusion Measurements—Feasibility Study. Radiology 2006; 238:586-96. [PMID: 16436819 DOI: 10.1148/radiol.2382041553] [Citation(s) in RCA: 90] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To prospectively assess feasibility of renal magnetic resonance (MR) perfusion measurement method based on turbo fast low-angle shot sequences for grading effect of renal artery stenosis (RAS) on parenchymal perfusion. MATERIALS AND METHODS Institutional review board approved this study, and patients gave written consent. Seventy-three patients (34 male, 39 female; age range, 17-84 years) who were clinically suspected of having RAS underwent contrast material-enhanced (gadodiamide) saturation-recovery turbo fast low-angle shot imaging for measurement of renal perfusion and high-spatial-resolution MR angiography for RAS detection and grading. Degree of stenosis was evaluated as high grade (>/=75% stenosis), low to intermediate grade (>0% to <75% stenosis), or absent. High temporal resolution of the turbo fast low-angle shot sequence allowed acquisition of an exact first-pass tracing of the contrast agent bolus from which a signal intensity (SI)-time curve was derived. On the basis of this curve, mean transit time (MTT) of the contrast agent bolus, maximal upslope (MUS) of the curve, maximum SI, and time to SI peak (TTP) were calculated with a gamma variate fit. Wilcoxon rank sum test, Pearson product moment correlation, and paired t test were used for statistical analysis. RESULTS Twenty-four renal arteries had high-grade RAS, 12 renal arteries had low- to intermediate-grade RAS, and 104 renal arteries had no RAS. Significant differences between patients without stenoses or with low- to intermediate-grade stenoses and patients with high-grade stenoses were found for MTT, MUS, and TTP (P < .001). Perfusion parameters were correlated with patients' serum creatinine levels, and significant correlations were found for MTT (r = 0.41), MUS (r = 0.48), and TTP (r = 0.4), with P < .001. CONCLUSION MR perfusion parameters can be used to assess effect of RAS on parenchymal perfusion. Perfusion measurements reflect renal function as measured with serum creatinine levels.
Collapse
Affiliation(s)
- Henrik J Michaely
- Institute of Clinical Radiology, University Hospitals-Grosshadern, Department of Internal Medicine, Division of Nephrology, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377 Munich, Germany.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Schoenberg S, Michaely HJ, Rieger J, Samtleben W, Reiser M. Diffuse und fokale Nierenparenchymveränderungen einschließlich der Ureteren. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-867358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
40
|
Lennertz A, Fertmann J, Thomae R, Illner WD, Hillebrand GE, Feucht HE, Land W, Samtleben W, Bosch T. Plasmapheresis in C4d-positive Acute Humoral Rejection Following Kidney Transplantation: A Review of 4 Cases. Ther Apher Dial 2003; 7:529-35. [PMID: 15018239 DOI: 10.1046/j.1526-0968.2003.00101.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Acute and chronic rejection after kidney transplantation has long been exclusively attributed to cellular and vascular mechanisms. Modern immunosuppressive therapy, therefore, addresses the cellular immune system. Rising experiences in kidney transplantation in the last few decades have revealed that some types of rejection are refractory to the conventional immunosuppressive treatment. Humoral rejection. which has previously been reported as a crucial factor in hyperacute rejection, is now suspected to play also an important role in acute and chronic rejection. Acute humoral rejection (AHR) is characterized by immunohistochemical detection of C4d deposits in peritubular capillaries. As shown for other antibody-mediated diseases, such as some autoimmune diseases, plasmapheresis has been suggested to be an efficient therapeutic approach in AHR. We present four patients with C4d-positive AHR in the early phase after kidney transplantation. In three of the four patients, humoral graft rejection was successfully treated by plasmapheresis. Graft function was significantly improved with a stable long-term outcome. One patient lost the graft. Although the number of patients with C4d-positive AHR treated by plasmapheresis is limited, plasma exchange appears to be an efficient and powerful therapeutic approach to control humoral rejection.
Collapse
Affiliation(s)
- Andrea Lennertz
- Nephrology Division, Department I of Internal Medicine, University Hospital Munich-Grosshadern, Munich, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Samtleben W, Dengler C, Reinhardt B, Nothdurft A, Lemke HD. Comparison of the new polyethersulfone high-flux membrane DIAPES(R) HF800 with conventional high-flux membranes during on-line haemodiafiltration. Nephrol Dial Transplant 2003; 18:2382-6. [PMID: 14551370 DOI: 10.1093/ndt/gfg410] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Current modalities of renal replacement therapy allow only a limited removal of larger, possibly toxic molecules, which accumulate in uraemia. Recently, a haemodiafilter has been made available with the new, high-flux, polyethersulfone-based membrane DIAPES HF800. We performed a study to compare DIAPES HF800 with two conventional high-flux membranes in on-line haemodiafiltration (HDF), with respect to the removal properties for the two marker proteins, beta(2)-microglobulin (beta(2)m, 11.8 kDa) and albumin (66.5 kDa). METHODS In a prospective, controlled study 10 stable end-stage renal disease patients were randomly allocated to 30 sessions of post-dilutional on-line HDF with three types of steam-sterilized membranes: DIAPES HF800, polysulfone and polyamide. Blood flow rate was 250 ml/min and treatment time was 240 min. Pre-treatment beta(2)m and albumin plasma concentrations did not differ between the three groups. The concentration of the two proteins was determined before and after treatment in plasma as well as in the continuously collected haemodiafiltrate. RESULTS Tolerance of all treatments was very good, without any side-effects for all filters. The mean plasma reduction rate of beta(2)m was 77 +/- 1% for DIAPES HF800 and polysulfone whereas it was 71 +/- 1% for polyamide (P < 0.05). The mean beta(2)m amount removed and found in the haemodiafiltrate per session was 230 +/- 14 mg for DIAPES HF800, 186 +/- 13 mg for polysulfone and 147 +/- 13 mg for polyamide (P < 0.05 between each pair of membranes). The same ranking was obtained for albumin removed and found in haemodiafiltrate per session for the three membranes: 5.7 +/- 0.4, 3.5 +/- 0.4 and 1.0 +/- 0.4 g, respectively. Although DIAPES HF800 showed the highest value for albumin in haemodiafiltrate the mean post-treatment plasma albumin was higher after the treatment with DIAPES HF800 compared with the other membranes (P < 0.05). CONCLUSIONS On-line HDF has shown to achieve plasma reduction rates for beta(2)m of up to 77% for the DIAPES HF800 membrane and for polysulfone. The amounts of beta(2)m and albumin in haemodiafiltrate were much higher for DIAPES HF800 than for the other two membranes indicating a greater permeability for molecules up to a molecular weight of 66.5 kDa. This could, at least theoretically, offer the advantage also to remove uraemic toxins in the molecular weight range of albumin or of albumin-bound toxins. The future must show whether this will counterbalance the loss of albumin.
Collapse
Affiliation(s)
- Walter Samtleben
- Department of Nephrology, University Hospital Munich-Grosshadern, Munich, Germany
| | | | | | | | | |
Collapse
|
42
|
Abstract
HISTORY AND CLINICAL FINDINGS A 54-year-old woman was referred for ambulant checkup after an episode of acute renal failure due to severe gastroenteritis and recurrent arthralgias. Physical examination was unremarkable except for the presence of palpable small cervical lymph nodes. INVESTIGATIONS Serum IgM levels showed a polyclonal increase. All the other routinely examined parameters were within normal limits. Microscopical blood smear examination revealed binucleated lymphocytes. Immunophenotyping of peripheral blood showed a polyclonal B-cell lymphocytosis despite normal numbers of leukocytes and lymphocytes. PCR analysis identified cells with a t(14;18) translocation (bcl-2/IgH rearrangement). DIAGNOSIS A routine medical checkup disclosed the diagnosis of persistent polyclonal B-cell lymphocytosis. This rare benign lymphoproliferative disorder is characterized by binucleated lymphocytes, polyclonal expansion of B-cells, and a polyclonal increase in serum IgM. The diagnosis was established despite the lack of leukocytosis or lymphocytosis in the peripheral blood. CONCLUSIONS Because of its benign and indolent course without the need for chemotherapy, it is important to discriminate the disorder of persistent polyclonal B-cell lymphocytosis from other malignant lymphoproliferative diseases.
Collapse
Affiliation(s)
- U Schönermarck
- Schwerpunkt Nephrologie, Medizinische Klinik und Poliklinik I, Klinikum der udwig-Maximilians-Universität München, Munich
| | | | | | | |
Collapse
|
43
|
Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002; 17:1072-6. [PMID: 12360562 DOI: 10.1002/mds.10231] [Citation(s) in RCA: 148] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Restless legs syndrome (RLS) is a common cause of sleep disturbance and is frequently experienced by hemodialysis patients. Factors triggering the disease in uremia have not yet been identified. To our knowledge, the course of RLS symptoms after kidney transplantation has not been investigated systematically. We investigated the clinical long-term course of RLS in hemodialysis patients who underwent kidney transplantation. Patients were given a standardized questionnaire three times: at baseline, and twice after their kidney transplants. The severity of RLS was rated by the patients (0 =no symptoms, 10 = very severe symptoms). The description of the final outcome was based on the last follow-up visit. Eleven of 64 hemodialysis patients with RLS received a transplant (5 men, 6 women; severity of RLS at baseline, 7.8 +/- 0.7 [mean +/- SEM]). In all patients, RLS symptoms disappeared within 1 to 21 days after transplantation. At follow-up visits, 4 patients whose transplanted kidneys still functioned well were still free of RLS symptoms up to the longest follow-up period of 9 years. In 3 other patients, RLS symptoms gradually reappeared (severity, 1 +/- 0). In 3 of 11 patients, the transplant failed and RLS symptoms reoccurred within 10 days to 2 months (severity, 7.3 +/- 2.6). RLS symptoms reoccurred in 1 patient with failure of the transplant but disappeared again after a second, successful transplant. Kidney transplantation has a strong and positive influence on RLS symptoms in hemodialysis patients. Hemodialysis patients can expect a substantial improvement of RLS symptoms after a successful kidney transplant.
Collapse
|
44
|
Bosch T, Lennertz A, Samtleben W. High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report. Ther Apher 2001; 5:358-63. [PMID: 11778920 DOI: 10.1046/j.1526-0968.2001.00365.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Direct adsorption of lipoproteins (DALI) apheresis is the first method for direct adsorption of lipoproteins from whole blood and is therefore an easy and rapid procedure. The majority of patients reaches >60% acute low-density lipoprotein cholesterol (LDL-C) reduction using either the DALI 750 or 1000 configuration. However, in patients with extremely high LDL-C levels or very large blood volumes, these configurations may lead to suboptimal results. The current study was performed to test the safety and efficacy of DALI 1250. In a severely obese patient (185 cm, 133 kg, blood volume 7.2 L, LDL-C 239 mg/dl), 11 L of blood (1.53-fold patient blood volume) was processed at a flow rate of 80 ml/min in 2.5 h; a combined heparin-plus-citrate anticoagulation regimen was used. Commercially available DALI 1250 and DALI hardware and disposables were manufactured by Fresenius HemoCare Adsorber Technology, St. Wendel, Germany. Twenty weekly sessions were performed. Clinically and technically, the apheresis sessions were completely uneventful. As compared to DALI 1000 (n = 4 sessions), the reduction rates by DALI 1250 (n = 20) improved for LDL-C (from 52% to 66%), lipoprotein (a) (Lp[a]) (53% vs. 66%), and fibrinogen (11% vs. 16%). There was a slight increase in high-density lipoprotein cholesterol (HDL-C) loss (20% vs. 24%). Moreover, the absolute amount of LDL-C removed per session increased from 5.06 g to 5.94 g. Laboratory safety parameters remained within the normal range, the anticoagulation was well controlled, and the pressure gradients over the adsorber remained constant. In this case report, DALI 1250 was perfectly safe and significantly increased the efficacy of LDL-C and Lp(a) elimination compared to standard DALI. Thus, this high-efficiency version of DALI may be used in patients with extremely high LDL-C levels and/or large blood volumes.
Collapse
Affiliation(s)
- T Bosch
- Department I of Internal Medicine, Klinikum Grosshadern, University of Munich, Germany.
| | | | | |
Collapse
|
45
|
Bosch T, Wendler T, Jaeger BR, Samtleben W. Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients. Ther Apher 2001; 5:372-6. [PMID: 11778922 DOI: 10.1046/j.1526-0968.2001.00368.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Plasma viscosity (PV) and erythrocyte aggregation (EA) are determinants of microcirculation, especially under the compromised hemodynamic conditions resulting from atherosclerosis. Direct adsorption of lipoproteins (DALI) apheresis is the first method for direct adsorption of lipoproteins; it drastically reduces low-density lipoprotein (LDL)-cholesterol and lipoprotein (a) (Lp[a]), and may therefore improve PV and EA. The current study was performed to test the effect of DALI on hemorheology. Six hypercholesterolemic patients who had been on regular LDL apheresis for at least several months were treated on a weekly or biweekly basis, on average 5 times each by DALI. Before and after each session, PV was measured by a capillary tube plasma viscosimeter and EA by rotational aggregometry. Single DALI sessions (n = 31) acutely decreased PV from 1.18 +/- 0.04 to 1.06 +/- 0.3 mPa (-10%) while EA improved from 22.8 +/- 4.4 to 13.3 +/- 4.5 (arbitrary units) (-42%). LDL-cholesterol, Lp(a), and very-low-density lipoprotein (VLDL)-cholesterol were effectively reduced while the decrease of triglycerides and fibrinogen was only moderate. DALI apheresis exerted an acute positive effect on blood hemorheology which may have beneficial effects on microcirculation. This hypothesis is in accordance with the clinical observation that in some patients, improvement of angina and/or exercise tolerance can be observed after only a few DALI sessions where changes of coronary stenoses cannot be expected yet.
Collapse
Affiliation(s)
- T Bosch
- Department I of Internal Medicine, Klinikum Grosshadern, Munich University Hospital, Germany.
| | | | | | | |
Collapse
|
46
|
Abstract
The potential to treat life-threatening conditions with therapeutic plasma exchange (TPE) is limited to a few situations. In severe pulmonary hemorrhage as a complication of several immune disorders (e.g., antiglomerular basement membrane antibody disease, Wegener's granulomatosus, lupus erythematosus), TPE should only be considered after conventional measures (mostly pulses of methylprednisolone) have been applied. Idiopathic familial and nonfamilial thrombotic thrombocytopenic purpura as well as the subset of the hemolytic uremic syndrome not associated with diarrhea are clear indications for TPE using fresh frozen plasma as replacement fluid. Patients with myasthenic crisis will also benefit from TPE and will improve within 1 day. Acute pancreatitis as a complication of the chylomicronemia syndrome has a poor prognosis and should be treated with TPE without any delay. In the case of drug overdose or intoxication, the efficiency of TPE to remove the offending drug is usually overestimated. In this situation, TPE is useful only when the plasma protein binding of the substance is high (>80%) and the volume of distribution is low (<0.2 L/kg body weight). TPE is not without risks and hazards (e.g., vascular access, bleeding, allergy), which should also be considered when discussing this extracorporeal therapy in otherwise refractory clinical conditions.
Collapse
Affiliation(s)
- W Samtleben
- Nephrology Division, Medical Clinic I, Klinikum Grosshadern, University of Munich, Germany.
| | | | | | | | | |
Collapse
|
47
|
|
48
|
Mistry-Burchardi N, Schönermarck U, Samtleben W. Apheresis in lupus nephritis. Ther Apher 2001; 5:161-70. [PMID: 11467751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/16/2023]
Abstract
Systemic lupus erythematosus is a chronic autoimmune disease which commonly involves the kidneys. Despite great improvement in survival over the past years due to immunosuppressive therapy, renal failure remains an important cause of morbidity and mortality. In view of the pathogenesis of lupus nephritis, the use of less toxic and more specific ways of treatment such as the extracorporeal removal of pathogenetically relevant autoantibodies seems rational. On the basis of currently available studies, plasma exchange used alone or as an adjunct to conventional immunosuppressive therapy offers no clear benefit over standard immunosuppression in patients with active lupus nephritis and therefore cannot be recommended. However, although not proven, plasmapheresis might be beneficial in patients with acute life-threatening disease, for which high-dose immunosuppressive therapy may not be possible, or as an adjunct procedure for patients not responding to conventional therapy. Rather than the unselective removal of plasma, adsorption procedures allow the selective or specific removal of immunoglobulins, which seems to be a more reasonable approach in lupus nephritis. The results of the first clinical trials using different adsorption columns seem promising, but their use cannot be recommended until well-designed, case-controlled studies have been performed to prove their usefulness and cost effectiveness in lupus nephritis. So far, clear-cut recommendations regarding type of adsorption column, intensity and duration of treatment, and accompanying immunosuppressive treatment cannot be given.
Collapse
Affiliation(s)
- N Mistry-Burchardi
- Department of Internal Medicine, Grosshadern, Ludwig Maximilians University, Munich, Germany.
| | | | | |
Collapse
|
49
|
Bolley R, Mistry-Burchardi N, Samtleben W. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up]. Dtsch Med Wochenschr 2000; 125:1519-25. [PMID: 11190761 DOI: 10.1055/s-2000-9478] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND AND OBJECTIVE Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) are primary necrotizing ANCA associated systemic vasculitides with preferential involvement of small and medium-sized vessels. It was the aim of this study to evaluate retrospectively data regarding diagnostic and clinical features collected over a long period on patients with WG and MPA at one medical centre. Additionally, the question was addressed whether both diseases are being more frequently diagnosed since the introduction of serological tests for ANCA. PATIENTS AND METHODS The files of all patients with WG (n = 48) and MPA (n = 6) seen between 1976 and 1997 by our nephrology team were evaluated with respect to clinical presentation (signs and symptoms, outcome, complications) and relevant laboratory data (e.g. blood count, ESR, renal function, CRP, ANCA). RESULTS Five of 48 patients with WG (24 males, 24 females, 22-67 and 18-77 years) had been diagnosed with the disease in the first 10 years before and 43 after ANCA serology became available. All MPA cases (6 males) had been diagnosed after 1992 and showed renal involvement. The pattern of organ involvement in this cohort with WG was the same as that recorded in the literature. Laboratory tests revealed raised ESR in 85%, anemia in 79%, ANCAs in 91% and increased CRP in 73%. A localized form of WG had been present in 15% of patients, the generalized in 85%. Treatment of the generalized form largely followed the Fauci scheme, achieving remission in 97%. After one year of immunosuppressive treatment 93% of patients with WG were still alive, 74% after 5 years. CONCLUSION This is the first report in Central Europe to have analysed data on patients with WG and MPA, followed up for 20 years at one centre. There were no significant differences in the pattern of organ involvement, results of treatment and prognosis from previously published multicenter studies. Our data demonstrate that the diagnosis of WG has been more frequently made since the introduction of immunological tests for ANCA.
Collapse
Affiliation(s)
- R Bolley
- Schwerpunkt Nephrologie der Medizinischen Klinik I, Klinikum der Ludwig-Maximilians-Universität München-Grosshadern
| | | | | |
Collapse
|
50
|
Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000; 11:2344-2350. [PMID: 11095657 DOI: 10.1681/asn.v11122344] [Citation(s) in RCA: 195] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Some of the morbidity associated with chronic hemodialysis is thought to result from retention of large molecular weight solutes that are poorly removed by diffusion in conventional hemodialysis. Hemodiafiltration combines convective and diffusive solute removal in a single therapy. The hypothesis that hemodiafiltration provides better solute removal than high-flux hemodialysis was tested in a prospective, randomized clinical trial. Patients were randomized to either on-line postdilution hemodiafiltration or high-flux hemodialysis. The groups did not differ in body size, treatment time, blood flow rate, or net fluid removal. The filtration volume in hemodiafiltration was 21 +/-1 L. Therapy prescriptions were unchanged for a 12-mo study period. Removal of both small (urea and creatinine) and large (ss(2)-microglobulin and complement factor D) solutes was significantly greater for hemodiafiltration than for high-flux hemodialysis. The increased urea and creatinine removal did not result in lower pretreatment serum concentrations in the hemodiafiltration group. Pretreatment plasma beta(2)-microglobulin concentrations decreased with time (P< 0.001); however, the decrease was similar for both therapies (P = 0.317). Pretreatment plasma complement factor D concentrations also decreased with time (P<0.001), and the decrease was significantly greater with hemodiafiltration than with high-flux hemodialysis (P = 0.010). The conclusion is that on-line hemodiafiltration provides superior solute removal to high-flux hemodialysis over a wide molecular weight range. The improved removal may not result in lower pretreatment plasma concentrations, however, possibly because of limitations in mass transfer rates within the body.
Collapse
Affiliation(s)
- Richard A Ward
- Department of Medicine, University of Louisville, Louisville, Kentucky
| | - Bärbel Schmidt
- Department of Medicine I, Klinikum Grosshadern, University of Munich, Munich
| | - Jeannine Hullin
- Department of Medicine I, Klinikum Grosshadern, University of Munich, Munich
| | - Günther F Hillebrand
- Department of Medicine I, Klinikum Grosshadern, University of Munich, Munich
- Kuratorium fuer Dialyse und Nierentransplantation, Neuried, Germany
| | - Walter Samtleben
- Department of Medicine I, Klinikum Grosshadern, University of Munich, Munich
- Kuratorium fuer Dialyse und Nierentransplantation, Neuried, Germany
| |
Collapse
|